Stephen Freedland, MD
@sfreedlandmd
Editor Emeritus of @pcan_journal; Dir of CIRCL, studying effects of lifestyle choices on cancer risk and progression; AD Education/Training @CSCancerCare.
ID: 3327967772
https://www.cedars-sinai.edu/Research/Research-Areas/CIRCL/ 24-08-2015 05:35:03
1,1K Tweet
1,1K Followers
499 Following
Great new option for men with high-risk BCR of prostate cancer - enzalutamide PLUS leuprolide. So great to work with this top-notch team in publishing our findings in NEJM this month. neal shore Cancer at Cedars-Sinai Professor Henry Woo Cedars-Sinai Pfizer Inc. Astellas Pharma US nejm.org/doi/full/10.10…